Detalhe da pesquisa
1.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; 41(33): 5140-5150, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561967
2.
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3ß inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Neurooncol Adv
; 4(1): vdac012, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35402914